Infliximab biosimilar - Pfizer
At a glance
- Drug Originator Pfizer
- Drug Licenced by Sandoz
- Drug Class Anti-inflammatories; Anti-TNF monoclonal antibodies; Antipsoriatics; Antirheumatics
- Mechanism of Action Tumour necrosis factor alpha inhibitors
- USA Patent Applicants PFIZER INC
- USA Patents 1
- BLAs 1
Table of Contents

Disclaimer